July 23, 2014 3:38 PM ET

Pharmaceuticals

Company Overview of Sentinel Oncology Limited

Company Overview

Sentinel Oncology Limited operates as a drug discovery company. It is developing a pipeline of small molecules oncology drugs for cancer treatment. Its pipe line of drugs is undergoing in-vivo evaluation. The company was founded in 2005 and is based in Cambridge, the United Kingdom.

23 Cambridge Science Park

Milton Road

Cambridge,  CB4 0EY

United Kingdom

Founded in 2005

Phone:

44 1223 437 123

Fax:

44 1223 437 125

Key Executives for Sentinel Oncology Limited

Co-Founder
Co-Founder and Director
Co-Founder
Compensation as of Fiscal Year 2014.

Sentinel Oncology Limited Key Developments

Sentinel Oncology, Ltd. Partners with Oncothyreon, Inc. for the Development of Sentinel's Checkpoint Kinase 1 (Chk1) Program

Sentinel Oncology Ltd. partnered with Oncothyreon Inc. for the development of Sentinel's Checkpoint Kinase 1 (Chk1) program. Under the terms of the agreement, Oncothyreon will fund additional drug discovery research at Sentinel directed at the Chk1 target, and will have an exclusive license for the development and commercialization of any resulting compounds. Sentinel is eligible to receive pre-clinical, clinical and commercial milestone payments of up to $174 million and a royalty on net sales, if any.

Similar Private Companies By Industry

Company Name Region
Brabant Pharma Limited Europe
EUSA Pharma (Europe) Ltd. Europe
C4X Discovery Limited Europe
Biofilm Limited Europe
Provita Eurotech Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sentinel Oncology Limited, please visit www.sentineloncology.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.